Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial - Université Claude Bernard Lyon 1 Access content directly
Journal Articles Familial Cancer Year : 2012

Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial

J. Lemonnier
  • Function : Author
L. Roca
  • Function : Author
S. Mijonnet
  • Function : Author
P. Gesta
  • Function : Author
J. Chiesa
  • Function : Author
H. Dreyfus
  • Function : Author
P. Vennin
  • Function : Author
C. Delnatte
  • Function : Author
Y. J. Bignon
  • Function : Author
A. Lortholary
  • Function : Author
F. Prieur
  • Function : Author
L. Gladieff
  • Function : Author
A. Lesur
  • Function : Author
K. B. Clough
  • Function : Author
C. Nogues
  • Function : Author
A-L. Martin
  • Function : Author
P. Pujol
  • Function : Author
P. Berthet
  • Function : Author
C. Dugast
  • Function : Author
S. Delaloge
  • Function : Author
J-P. Fricker
  • Function : Author
I. Tennevet
  • Function : Author
N. Chabbert-Buffet
  • Function : Author
P. This
  • Function : Author
K. Baudry
  • Function : Author

Dates and versions

hal-02282759 , version 1 (10-09-2019)

Identifiers

Cite

J. Lemonnier, L. Roca, S. Mijonnet, P. Gesta, J. Chiesa, et al.. Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial. Familial Cancer, 2012, 11, pp.77-84. ⟨10.1007/s10689-011-9484-4⟩. ⟨hal-02282759⟩
19 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More